These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24025988)

  • 1. Effects of peritoneal dialysis on pharmacotherapy: a deductive pharmacokinetic-model approach to predict drug concentration profiles in plasma and peritoneal fluid.
    Horiuchi M; Moriyama S; Takahata Y; Aiba T; Kurosaki Y
    Drug Metab Pharmacokinet; 2014; 29(2):154-61. PubMed ID: 24025988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal dialysis alters tolbutamide pharmacokinetics in rats with experimental acute renal failure.
    Aiba T; Horiuchi M; Makita T; Komori Y; Kawasaki H; Kurosaki Y
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):291-6. PubMed ID: 16946556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased.
    Makita T; Aiba T; Izuwa Y; Komori Y; Kawasaki H; Kurosaki Y
    Biopharm Drug Dispos; 2009 Jan; 30(1):1-8. PubMed ID: 19148953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Cefalothin and Cefazolin in Human Plasma, Urine and Peritoneal Dialysate by UHPLC-MS/MS: application to a pilot pharmacokinetic study in humans.
    Parker SL; Guerra Valero YC; Roberts DM; Lipman J; Roberts JA; Wallis SC
    Biomed Chromatogr; 2016 Jun; 30(6):872-9. PubMed ID: 26394804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure.
    Izuwa Y; Kusaba J; Horiuchi M; Aiba T; Kawasaki H; Kurosaki Y
    Drug Metab Pharmacokinet; 2009; 24(5):451-7. PubMed ID: 19881257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?
    Zeier M; Schwenger V; Deppisch R; Haug U; Weigel K; Bahner U; Wanner C; Schneider H; Henle T; Ritz E
    Kidney Int; 2003 Jan; 63(1):298-305. PubMed ID: 12472796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of increased dialysate fill volume on peritoneal fluid and solute transport.
    Wang T; Heimbürger O; Cheng H; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1997 Oct; 52(4):1068-76. PubMed ID: 9328947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B; Levin L
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome-supported peritoneal dialysis in the treatment of severe hyperammonemia: An investigation on potential interactions.
    Giacalone G; Matoori S; Agostoni V; Forster V; Kabbaj M; Eggenschwiler S; Lussi M; De Gottardi A; Zamboni N; Leroux JC
    J Control Release; 2018 May; 278():57-65. PubMed ID: 29601930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
    Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
    Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of propranolol in peritoneal dialysis fluid by high-performance liquid chromatography without extraction.
    Parrott KA
    J Chromatogr; 1983 May; 274():171-8. PubMed ID: 6874819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal dialysis after infant open heart surgery: observations in 27 patients.
    Dittrich S; Dähnert I; Vogel M; Stiller B; Haas NA; Alexi-Meskishvili V; Lange PE
    Ann Thorac Surg; 1999 Jul; 68(1):160-3. PubMed ID: 10421133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of peritoneal dialysate flow rate on the pharmacokinetics of cefazolin.
    Manley HJ; Bridwell DL; Elwell RJ; Bailie GR
    Perit Dial Int; 2003; 23(5):469-74. PubMed ID: 14604200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal transport of beta-lactam antibiotics: effects of plasma protein binding and the interspecies relationship.
    Deguchi Y; Nakashima E; Ishikawa F; Sato H; Tamai I; Matsushita R; Tofuku Y; Ichimura F; Tsuji A
    J Pharm Sci; 1988 Jul; 77(7):559-64. PubMed ID: 3171941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic analyses of antihypertensive drugs, nifedipine and propranolol, in spontaneously hypertensive rats to investigate characteristics of effect and side effects.
    Kiriyama A; Honbo A; Nishimura A; Shibata N; Iga K
    Regul Toxicol Pharmacol; 2016 Apr; 76():21-9. PubMed ID: 26773344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peritoneal dialysis for acute renal failure: Rediscovery of an old modality of renal replacement therapy].
    Issad B; Rostoker G; Bagnis C; Deray G
    Nephrol Ther; 2016 Jul; 12(4):193-7. PubMed ID: 27318887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Anderstam B; Heimbürger O; Bergström J; Waniewski J; Breborowicz A; Lindholm B
    Nephrol Dial Transplant; 2001 Mar; 16(3):669-71. PubMed ID: 11239065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of fluconazole and fosfluconazole after intraperitoneal administration to peritoneal dialysis rats.
    Aoyama T; Ogata K; Shimizu M; Hatta S; Masuhara K; Shima Y; Kimura K; Matsumoto Y
    Drug Metab Pharmacokinet; 2005 Dec; 20(6):485-90. PubMed ID: 16415533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Monte Carlo analysis of peritoneal antimicrobial pharmacokinetics.
    Hota S; Crooke P; Hotchkiss J
    Adv Exp Med Biol; 2011; 696():401-10. PubMed ID: 21431580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan decreases peritoneal fluid absorption: effect of molecular weight and concentration of hyaluronan.
    Wang T; Cheng HH; Heimbürger O; Chen C; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1999 Feb; 55(2):667-73. PubMed ID: 9987091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.